Predict your next investment

Elekta company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
elekta.com

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

Partners & Customers

10

About Elekta

Elekta is a human-care company focused on clinical solutions for treating cancer and brain disorders. The company develops tools and treatment-planning systems for radiation therapy and radiosurgery, as well as workflow-enhancing software systems across the spectrum of cancer care. Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Elekta Headquarter Location

Kungstensgatan 18

Stockholm, 103 93,

Sweden

+46 8587 254 00

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Elekta

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Elekta in 4 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health IT

1,191 items

M

Medical Devices

3,500 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

Elekta Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Elekta Rank

Latest Elekta News

Elekta: Interim report, May-October 2021/22

Nov 25, 2021

11/25/2021 | 03:41am EST Message : *Required fields STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew with double digits, and despite the continued global supply chain challenges we secured good revenue growth supported by a strong finish of the quarter. Our margins improved sequentially but were still impacted by higher logistics costs. Gustaf Salford Second quarter          Gross order intake amounted to SEK 4,045 M (3,627), corresponding to a 12 percent increase in constant currency            Net sales were SEK 3,697 M (3,534), corresponding to a 7 percent growth in constant currency           Gross margin amounted to 38.6 percent (40.9)          EBIT amounted to SEK 533 M (559), corresponding to an EBIT margin of 14.4 percent (15.8)            Earnings per share was SEK 1.00 (0.98) before/after dilution            Cash flow after continuous investments decreased by SEK 379 M to SEK -17 M (362) First six months          Gross order intake amounted to SEK 8,025 M (8,078), corresponding to a 3 percent growth in constant currency            Net sales were SEK 6,707 M (6,515), corresponding to a 7 percent increase in constant currency            Gross margin amounted to 37.9 (43.2) percent          EBIT amounted to SEK 734 M (893), corresponding to an EBIT margin of 10.9 percent (13.7)            Earnings per share was SEK 1.33 (1.55) before/after dilution            Cash flow after continuous investments decreased by SEK 749 M to SEK -360 M (389) Group summary Johan Adebäck, CFO, Elekta AB (publ) Tel: +46 70 873 33 21, e-mail: johan.adeback@elekta.com Time zone: CET: Central European Time Cecilia Ketels, Head of Investor Relations Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com Time zone: CET: Central European Time Kira Haapanen, IR Manager Time zone: CET: Central European Time This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on November 25, 2021. (REGMAR)   About Elekta As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com  or follow @Elekta  on Twitter. This information was brought to you by Cision http://news.cision.com

Elekta Investments

2 Investments

Elekta has made 2 investments. Their latest investment was in iRT Systems as part of their Corporate Minority on April 4, 2019.

CBI Logo

Elekta Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/9/2019

Corporate Minority

iRT Systems

Yes

1

3/23/2018

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/9/2019

3/23/2018

Round

Corporate Minority

Corporate Minority

Company

iRT Systems

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Elekta Portfolio Exits

1 Portfolio Exit

Elekta has 1 portfolio exit. Their latest portfolio exit was Elekta - Magnetoencephalography (MEG) Business on July 25, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/25/2018

Divestiture

2

Date

7/25/2018

Exit

Divestiture

Companies

Valuation

Acquirer

Sources

2

Elekta Acquisitions

13 Acquisitions

Elekta acquired 13 companies. Their latest acquisition was Özyürek on September 08, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/8/2021

Acquired

1

5/19/2020

Series A

$6.34M

Acquired

1

2/21/2020

Corporate Minority

$2M

Acquired

1

8/29/2019

Subscribe to see more

$99M

Subscribe to see more

10

7/27/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/8/2021

5/19/2020

2/21/2020

8/29/2019

7/27/2018

Investment Stage

Series A

Corporate Minority

Companies

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$6.34M

$2M

$99M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Elekta Partners & Customers

10 Partners and customers

Elekta has 10 strategic partners and customers. Elekta recently partnered with Philips on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/21/2021

Partner

Philips

Netherlands

Philips brings clarity to every moment of cancer care with new patient-centered innovations at ASTRO 2021

As part of the partnership , Philips will develop seamless integration between its precision medicine applications and Elekta 's MOSAIQ Plaza integrated radiotherapy software suite , enhancing end-to-end decision making and treatment implementation .

1

7/26/2021

Client

GenesisCare

Australia

GenesisCare Extends U.S. Brachytherapy Service With 27 Elekta Flexitron Treatment Devices

`` GenesisCare 's partnership with Elekta makes it easier to improve access for cancer patients and to ensure we can deliver the highest standards of care possible . ''

2

7/23/2021

Client

GenesisCare USA

United States

GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

`` GenesisCare 's partnership with Elekta makes it easier to improve access for cancer patients and to ensure we can deliver the highest standards of care possible . ''

1

6/7/2021

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

11/4/2020

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/21/2021

7/26/2021

7/23/2021

6/7/2021

11/4/2020

Type

Partner

Client

Client

Partner

Vendor

Business Partner

Philips

GenesisCare

GenesisCare USA

Country

Netherlands

Australia

United States

Subscribe to see more

Subscribe to see more

News Snippet

Philips brings clarity to every moment of cancer care with new patient-centered innovations at ASTRO 2021

As part of the partnership , Philips will develop seamless integration between its precision medicine applications and Elekta 's MOSAIQ Plaza integrated radiotherapy software suite , enhancing end-to-end decision making and treatment implementation .

GenesisCare Extends U.S. Brachytherapy Service With 27 Elekta Flexitron Treatment Devices

`` GenesisCare 's partnership with Elekta makes it easier to improve access for cancer patients and to ensure we can deliver the highest standards of care possible . ''

GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

`` GenesisCare 's partnership with Elekta makes it easier to improve access for cancer patients and to ensure we can deliver the highest standards of care possible . ''

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

Elekta Team

9 Team Members

Elekta has 9 team members, including former Chief Executive Officer, Niklas Savander.

Name

Work History

Title

Status

Niklas Savander

Conor Venture Partners, Nokia, and Hewlett Packard Enterprise

Chief Executive Officer

Former

Jack Coats

President

Former

Johan Sedihn

Chief Operating Officer, Executive Vice President

Former

Peter Kingma

Executive Vice President

Former

Todd Powell

Executive Vice President, Senior Vice President

Former

Name

Niklas Savander

Jack Coats

Johan Sedihn

Peter Kingma

Todd Powell

Work History

Conor Venture Partners, Nokia, and Hewlett Packard Enterprise

Title

Chief Executive Officer

President

Chief Operating Officer, Executive Vice President

Executive Vice President

Executive Vice President, Senior Vice President

Status

Former

Former

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.